Hester Biosciences announced that the Board of Directors of the Company at its meeting held on 10 May 2024, inter alia, have recommended the final dividend of Rs 6 per equity Share (i.e. 60%) , subject to the approval of the shareholders.Powered by Capital Market - Live News

Net profit of Hester Biosciences rose 9.27% to Rs 4.95 crore in the quarter ended March 2024 as against Rs 4.53 crore during the previous quarter ended March 2023. Sales rose 17.77% to Rs 79.26 crore in the quarter ended March 2024 as against Rs 67.30 crore during the previous quarter ended March 2023.For the full year,net profit declined 29.06% to Rs 18.89 crore in the year ended March 2024 as against Rs 26.63 crore during the previous year ended March 2023. Sales rose 14.45% to Rs 304.55 crore in the year ended March 2024 as against Rs 266.09 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales79.2667.30 18 304.55266.09 14 OPM %20.0917.34 -17.6219.02 - PBDT13.6113.79 -1 49.1360.85 -19 PBT9.878.42 17 31.9540.15 -20 NP4.954.53 9 18.8926.63 -29 Powered by Capital Market - Live News

Hester Biosciences will hold a meeting of the Board of Directors of the Company on 10 May 2024.Powered by Capital Market - Live News

Net profit of Hester Biosciences declined 64.43% to Rs 3.98 crore in the quarter ended December 2023 as against Rs 11.19 crore during the previous quarter ended December 2022. Sales declined 10.62% to Rs 66.98 crore in the quarter ended December 2023 as against Rs 74.94 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales66.9874.94 -11 OPM %15.1525.03 - PBDT10.1621.24 -52 PBT6.4116.00 -60 NP3.9811.19 -64 Powered by Capital Market - Live News

Hester Biosciences will hold a meeting of the Board of Directors of the Company on 2 February 2024.Powered by Capital Market - Live News